Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
The companies will work with investigators to share the results with the scientific community
The companies will work with investigators to share the results with the scientific community
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Subscribe To Our Newsletter & Stay Updated